Cargando…
Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium
INTRODUCTION: ALRV5XR treatment of androgenetic alopecia (AGA) and telogen effluvium (TE) has early evidence of regenerating a normal scalp hair phenotype in both sexes. DESIGN: We performed two 24-week double-blinded placebo-controlled comparison trials, one in each sex, on the ALRV5XR treatment ef...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421616/ https://www.ncbi.nlm.nih.gov/pubmed/36045927 http://dx.doi.org/10.3389/fmed.2022.918058 |